Stories about Glaxosmithkline Plc
Coronavirus update: Global case tally tops 30 million, and controversial CDC testing guideline changes were reportedly not made by CDC scientists
September 18, 2020
From MarketWatch
Dr. Fauci: ‘We may be able to put this coronavirus outbreak behind us’ — but says the American public must play a critical role
September 18, 2020
From MarketWatch
Is AstraZeneca Still A Safe Bet?
September 17, 2020
From Benzinga
Dr. Offit: Prepare to wear masks and socially distance even after getting COVID-19 vaccine
September 17, 2020
From MarketWatch
Sorrento Surges On FDA Nod For Initiating Clinical Study Of COVID-19 Antibody Treatment
September 17, 2020
From Benzinga
Lilly's Coronavirus Antibody Treatment Found Effective, Safe In Mild-To-Moderate Patients
September 16, 2020
From Benzinga
Seattle Genetics Pact With Drug Giant Merck Sends SGEN Stock Soaring
September 14, 2020
The Daily Biotech Pulse: FDA Nod For GlaxoSmithKline, Sarepta Flags Potential Delay In Gene Therapy Trial
September 10, 2020
From Benzinga
AstraZeneca’s coronavirus vaccine setback shows why Big Pharma would rather be safe than sorry
September 09, 2020
From MarketWatch
The Daily Biotech Pulse: AstraZeneca Pauses Coronavirus Vaccine Study, Trillium To Get $25M Pfizer Investment
September 09, 2020
From Benzinga
6 Companies Racing to Mass-Produce a Coronavirus Vaccine in 2021
September 09, 2020
From Motley Fool
Market Briefing For Wednesday, September 9
September 09, 2020
From Blogs - TalkMarkets
AstraZeneca Shares Drop 8% As Advanced COVID-19 Vaccine Trials Are Halted
September 08, 2020
From Benzinga
As Political Pressure Mounts, COVID-19 Vaccine Developers Pledge To Put Safety First
September 08, 2020
From Benzinga
There are seven coronavirus vaccine candidates being tested in the U.S. — here’s where they stand
September 08, 2020
From MarketWatch
Coronavirus update: Global case tally tops 27.3 million, U.S. accounts for a quarter and 9 drug maker CEOs pledge to ‘stand with science’ in developing vaccine
September 08, 2020
From MarketWatch
P/E Ratio Insights for GlaxoSmithKline
September 08, 2020
From Benzinga
My parents have $50,000 in credit-card debt and $50,000 in a home-equity loan. My father works part-time and my mother refuses to work. How can we help?
September 08, 2020
From MarketWatch
Sanofi COVID-19 vaccine to cost below €10 and drug ingredients IPO planned within months, its France chief says
September 07, 2020
Tags
GSK
From MarketWatch
Some COVID-19 patients suffer lung and heart damage, but there’s encouraging news for these ‘long haulers’
September 07, 2020
From MarketWatch
Benzinga's Bulls And Bears Of The Week: Apple, Costco, FedEx And More
September 06, 2020
From Benzinga
Moderna, Pfizer, Johnson & Johnson, And Others To Make Pledge in Response to Coronavirus Vaccine Political Pressure
September 04, 2020
From Motley Fool
Coronavirus update: Global cases climb above 26.3 million, and U.S. vaccine program head sees very low chance of vaccine by late October
September 04, 2020
From MarketWatch
Like Dividends? I Bet You'll Love These 2 Stocks
September 04, 2020
From Motley Fool
From Benzinga
Better Late Than Never: Sanofi and GlaxoSmithKline Start Coronavirus Vaccine Clinical Trial Program
September 03, 2020
From Motley Fool
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.